Non-sedating antihistamines and cardiac arrhythmias [10]

Lancet

Volumn 351, Issue 9100, 1998, Pages 451-

  Coulie, P ^a   Delaere, A ^a   De Vos, C ^a   Donnelly, F ^a   Rihoux, J P ^a  

^a UCB PHARMA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; AZITHROMYCIN; CETIRIZINE; ERYTHROMYCIN; KETOCONAZOLE;

DRUG DISTRIBUTION; DRUG METABOLISM; DRUG PENETRATION; DRUG SAFETY; HEART ARRHYTHMIA; LETTER; LIVER METABOLISM; PRIORITY JOURNAL; QT INTERVAL; RISK; TORSADE DES POINTES;

EID: 0032492171     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)78403-8     Document Type: Letter

References (5)

1. M Lindquist IR Edward Risks of non-sedating antihistamines Lancet 349 1997 1322
2. ME Sale JT Barbey RL Woosley The electrocardiographic effects of cetirizine in normal subjects Clin Pharmacol Ther 56 1994 295 301
3. ME Sale RL Woosley K Thakker K Phillips F Caridi M Chung Effects of cetirizine and erythromycin, alone and in combination on QT interval and pharmacokinetics in healthy subjects Ann Allergy Asthma Immunol 76 1996 93
4. M Sale R Woosley K Thakker K Phillips F Cardidi M Chung A randomized, placebo-controlled, multiple-dose study to evaluate the electrocardiographic and pharmacokinetic interactions of azithromycin and cetirizine Ann Allergy Asthma Immunol 76 1996 93
5. AC Rankin Non-sedating antihistamines and cardiac arrhythmia Lancet 350 1997 1115 1116